Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00565682
Other study ID # DOLAAR
Secondary ID
Status Completed
Phase Phase 4
First received November 29, 2007
Last updated November 29, 2007
Start date April 2006
Est. completion date December 2006

Study information

Verified date November 2007
Source Hospital Vozandez
Contact n/a
Is FDA regulated No
Health authority Ecuador: Public Health Ministry
Study type Interventional

Clinical Trial Summary

To test the analgesic efficacy of etoricoxib used before a surgical procedure compared to the already known effect when administered after such a procedure. Patient will be receiving either etoricoxib or the respective placebo one hour before surgery, then two hours after those receiving the active will receive placebo and those that received placebo will be given etoricoxib. Pain score measurements will be performed sequentially. Rescue medication will be available all the time.


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date December 2006
Est. primary completion date
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria:

- Voluntary acceptance to participate in the study and signed the informed consent form

- Age older than 18 years old and younger than 70 years

- Diagnosis of appendicitis, cholecystitis or ovarian cysts suitable of laparoscopic surgery

Exclusion Criteria:

- Age less than 18 years or older than 70 years.

- Laparoscopic procedures for diagnostic purposes.

- Current use of anticoagulants.

- Known hypersensitivity to etoricoxib or its components.

- History of a CABG or MI (less than 1 year)

- History of unstable angina (over the past six months).

- Current inflammatory bowel disease.

- Uncontrolled hypertension or heart failure

- Renal dysfunction/impairment (creatinine clearance < 30ml/min)

- Cirrhosis or severe hepatic dysfunction

- Any degree of dehydration (mild to severe)

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Drug:
etoricoxib 120 mg
etoricoxib 120 mg, tablet, orally, OD

Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
Hospital Vozandez Merck Sharp & Dohme Corp.

Outcome

Type Measure Description Time frame Safety issue
Primary To measure the amount of rescue medication (opioid) needed to relief Every hour after surgery No
Secondary To determine the overall analgesic effect using the visual analog scale (VAS) Every hour after surgery No